Author:
Perlis Roy H.,Fava Maurizio,McCoy Thomas H.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference10 articles.
1. Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009;166:599–607.
2. Carroll J. AstraZeneca cutting 2,200 R&D jobs, slashing neuroscience in restructuring [Internet]. 2012. Available from:
https://www.fiercebiotech.com/r-d/updated-astrazeneca-cutting-2-200-r-d-jobs-slashing-neuroscience-restructuring.
3. Bech P. Rating scales in depression: limitations and pitfalls. Dialog Clin Neurosci. 2006;8:207–15.
4. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, et al. DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170:59–70.
5. Sellgren C, Sheridan S, Gracias J, Xuan D, Fu T, Perlis R. Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol Psychiatry. 2017;22:170–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献